Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Johnson & Johnson
Gilead Sciences
Luye Pharma
Sun Pharmaceutical
Pacira
Fudan-Zhangjiang
Sigma-Tau Group
Teva Pharmaceutical
CSPC
Novartis
Crucell
Celsion Corporation
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Liposomes Drug Delivery Picture
1.1.2 Specifications
Table Product Specifications of Liposomes Drug Delivery
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market by Type, 2011-2022 (USD Million)
1.2.1.1 Liposomal doxorubicin
Table Liposomal doxorubicin Overview
1.2.1.2 Liposomal Amphoteracin B
Table Liposomal Amphoteracin B Overview
1.2.1.3 Liposomal Paclitaxel
Table Liposomal Paclitaxel Overview
1.2.1.4 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market by Application, 2011-2022 (USD Million)
1.2.2.1 Fungal Infection Therapy
Table Fungal Infection Therapy Overview
1.2.2.2 Cancer Therapy ( Tumor therapy)
Table Cancer Therapy ( Tumor therapy) Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Liposomes Drug Delivery Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Liposomes Drug Delivery
2.2 Upstream
Table Cost of Liposomes Drug Delivery
Figure Manufacturing Process of Liposomes Drug Delivery
2.3 Market
2.3.1 SWOT
Figure SWOT of Liposomes Drug Delivery
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Liposomes Drug Delivery
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Liposomes Drug Delivery
3.4 Market Entry
Table Market Entry of Liposomes Drug Delivery
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Liposomal doxorubicin Market, 2013-2018
Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (in Volume)
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2018
4.1.2 Liposomal Amphoteracin B Market, 2013-2018
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (in Volume)
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2018
4.1.3 Liposomal Paclitaxel Market, 2013-2018
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (in Volume)
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2018
4.1.4 Others Market, 2013-2018
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2018
Summary: Get latest Market Research Reports on Liposomes Drug Delivery. Industry analysis & Market Report on Liposomes Drug Delivery is a syndicated market report, published as Global Liposomes Drug Delivery Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Liposomes Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.